10514-14-4Relevant academic research and scientific papers
Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents
Woodard,Debnath,Simlot,Izydore,Daniels,Wong,ElSourady,Hall
, p. 24 - 38 (1995)
A series of 2-benzoyl-4,4-dialkyl-3,5-isoxazolidinediones proved to have potent hypolipidemic activity, lowering both serum cholesterol and triglyceride levels at 10 or 20 mg/kg/day, IP and orally in rodents. 2-(3,4,5-Trimethoxybenzoyl)-4,4-diethyl-3,5-is
Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
-
, (2008/06/13)
An isoxazolidin-3,5-dione for the control of hyperlipidemia in mammals having the following structural formula: STR1 wherein R1 and R2 are each an alkyl of 1 to 4 carbons; R3 is an alkoxybenzoyl group containing from 1 to 3 alkoxy groups wherein the alkoxy groups have from 1 to 4 carbon atoms, an alkoxybenzoyl group wherein the alkyl group had from 1 to 4 carbons, a halobenzoyl group, or a group STR2 where together R10 and R11 form a C3 to C7 alkylene group, and R12 and R13 are each alkyl from 1 to 4 carbon atoms.
